The medical cannabis market in Europe is on the verge of significant growth and development. The market value, which is expected to grow from $3.41 billion...
Ireland's consultation on drug decriminalization coincides with a major EU study into the heroin market, which warns that the near-total collapse of opium production in Afghanistan...
The Cann-L project is expected to cost 1.7 million Swiss francs and take four and a half years. Participants will complete surveys every six months, and...
To investigate the long-term effects of cannabis use in people with ADHD, researchers in this study analyzed data from 68 ADHD patients from the British Medical...
The average depression severity score among study participants, measured on a scale from 0 to 10, was initially 6.9 points. After six weeks of medical cannabis...
The cannabis packaging market in North America is on a dynamic development path, driven by innovation, environmental awareness, and legislative changes. The North American cannabis packaging...
The cannabis market appears to be an arena of fierce competition between legal and illegal sales channels. According to a 2022 report by “New Frontier Data,”...
In the initial years of development of the Ukrainian medical cannabis market, import will be crucial. Before domestic crops begin to play their role, imported products...
On August 29th, 2023, the U.S. HHS recommended to the DEA that cannabis be reclassified from a Schedule I drug to a Schedule III drug. Rescheduling...
In Thailand, many people have benefited from the cannabis boom. Now it could mean the end for the cannabis industry. An entrepreneur from Bangkok describes the...